Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-21
    E.g., 2018-06-21

Articles

Pages

3459 items
12:31 PM, Jun 15, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Alta closes $130M fund for biotechs, tech-based healthcare services

Alta Partners (San Francisco, Calif.) closed its Alta Partners NextGen Fund I at $130 million to invest in biotech and healthcare delivery companies. Alta told BioCentury the fund will invest in about six to eight...
8:17 AM, Jun 08, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Pfizer allocates $600M to venture, with neuroscience a focus

Pfizer Inc. (NYSE:PFE) on June 6 said it will invest $600 million in biotech and other emerging growth companies via Pfizer Ventures, with about $150 million devoted to early stage neuroscience companies. Pfizer said initial...
12:20 PM, Jun 01, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Decheng to raise $450M life sciences fund

Decheng Capital (Shanghai, China) proposed to raise up to $450 million for its Decheng Capital China Life Sciences USD Fund III, according to an April 30 SEC filing. The firm typically invests in early stage life...
10:56 AM, Jun 01, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Loncar to launch China BioPharma ETF

Loncar Investments LLC aims to create the Loncar China BioPharma ETF on NASDAQ, according to an SEC filing. The ETF would be based on the Loncar China BioPharma Index (LCHINA), which was unveiled in March as...
11:32 AM, May 25, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Pivotal closes China fund at $150M

Pivotal bioVenture Partners China closed on May 24 its USD Fund I at $150 million to invest in Chinese biotechs with in-licensed portfolios. Pivotal China's Jimmy Wei told BioCentury the VC plans to raise another...
11:20 AM, May 25, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Consonance, Jay Mohr partner to invest in deprioritized therapeutics

Through a collaboration with biotech executive Jay Mohr, Consonance Capital Partners (New York, N.Y.) plans to make its first therapeutics investments out of its $500 million private equity fund, with the aim of increasing the...
8:28 AM, May 25, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Biomatics raising $300M fund

Biomatics Capital Partners (Seattle, Wash.) has set a $300 million target for its second venture fund, according to a May 17 SEC filing. Biomatics, which invests in genomics and digital health companies, closed its first $200...
8:28 AM, May 25, 2018  |  BC Week In Review | Financial News  |  Other Financial News

CalPERS considers direct private investment

California Public Employees' Retirement System proposed on May 17 creating two private investment funds representing as much as 10% of its portfolio, which equates to investing about $13 billion a year. One fund would be focused...
10:54 AM, May 11, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Healthcare firm Linden closes fourth fund at $1.5B

Healthcare private equity firm Linden Capital (Chicago, Ill.) closed its Linden Capital Partners IV fund at $1.5 billion, exceeding its $1.3 billion target. The firm invests in middle market platforms in the medical products, specialty distribution,...
11:56 AM, May 04, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Foresite closes $668M fund

Foresite Capital Management closed Foresite Capital Fund IV with $668 million on May 3. The fund will invest in companies using data science and machine learning in drug discovery and development, diagnostics and patient care (see...

Pages